Insiders · ALPN

Robert E Conway

Director at Alpine Immune Sciences, Inc. (ALPN)

Robert E Conway has filed 11 insider reports with the SEC since May 2021, as director at Alpine Immune Sciences, Inc. (ALPN) and chairman of the Board and director at ARCA biopharma, Inc. (ORKA). Robert E Conway made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2024, reports sale back to the company at Alpine Immune Sciences, Inc. (ALPN).

Filings
11
Companies
2
Bought on market
$313K
Sold on market
None

Companies where Robert E Conway is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Alpine Immune Sciences, Inc. logo
ALPN
Alpine Immune Sciences, Inc.
Director$249K$9.96May 21, 2024
ARCA biopharma, Inc. logo
ORKA
ARCA biopharma, Inc.
Chairman of the Board, Director50,000$64.3K$3.21$96.32+2901%Jan 31, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Robert E Conway with

Other insiders at the same companies

Questions about Robert E Conway

What is Robert E Conway's role at Alpine Immune Sciences, Inc.?
Robert E Conway reports to the SEC as director at Alpine Immune Sciences, Inc. (ALPN), according to the latest filing on May 21, 2024. Robert E Conway has also filed as chairman of the Board and director at ARCA biopharma, Inc. (ORKA).
How many shares does Robert E Conway own?
After the latest filing that states it, Robert E Conway directly owned 50,000 shares of ARCA biopharma, Inc. (ORKA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert E Conway bought or sold stock recently?
The most recent open-market purchase was on September 23, 2021: bought 15,000 shares of Alpine Immune Sciences, Inc. (ALPN) for $151K at an average of $10.08.
How do I get alerts when Robert E Conway files?
Follow Robert E Conway on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert E Conway (SEC CIK 0001184334). Totals count each trade once, skipping amendments whose original is on file, from May 6, 2021 on. View on SEC EDGAR